DEL GIUDICE, TERESA
 Distribuzione geografica
Continente #
NA - Nord America 47
AS - Asia 33
EU - Europa 28
SA - Sud America 4
Totale 112
Nazione #
US - Stati Uniti d'America 45
SG - Singapore 26
DE - Germania 14
BR - Brasile 4
GB - Regno Unito 4
FI - Finlandia 3
SE - Svezia 3
IN - India 2
IT - Italia 2
MX - Messico 2
AT - Austria 1
BD - Bangladesh 1
CN - Cina 1
HK - Hong Kong 1
TR - Turchia 1
UA - Ucraina 1
VN - Vietnam 1
Totale 112
Città #
Munich 13
Singapore 12
Chandler 6
Chicago 3
London 3
Santa Clara 3
Turku 3
Lawrence 2
Milan 2
Princeton 2
Ashburn 1
Boardman 1
Boston 1
Brooklyn 1
Buffalo 1
Campinas 1
Chennai 1
Corona 1
Guadalajara 1
Hanoi 1
Hong Kong 1
Irving 1
Kolkata 1
Norwalk 1
Phoenix 1
Raleigh 1
Rio de Janeiro 1
Saint Louis 1
Shenzhen 1
São João da Barra 1
Taboão da Serra 1
Wilmington 1
Wisbech 1
Totale 72
Nome #
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 44
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 38
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC) 14
Immune-related [18F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications 14
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 8
Totale 118
Categoria #
all - tutte 1.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 3 0 0 0 0 0 0
2021/20227 0 0 0 3 0 0 0 1 1 2 0 0
2022/202324 4 1 2 0 3 1 0 2 6 2 2 1
2023/20248 4 0 0 0 1 2 0 0 0 0 0 1
2024/202566 3 0 4 1 3 8 2 1 7 0 15 22
2025/202610 10 0 0 0 0 0 0 0 0 0 0 0
Totale 118